Atlas Trials

Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)

Clinical trial NCT04707300 · RECRUITING

Trial details

NCT number
NCT04707300
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic Malignancy
Start date
2022-02-16
Primary completion
2027-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.